{
  "id": 7575114,
  "title": "Rocket's Danon plans; Novo leaves Ascendis; Lilly's latest deal",
  "url": "https://urgent.news/2026/09/15/rockets-danon-plans-novo-leaves-ascendis-lillys-latest-deal",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-15T15:19:06.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/rockets-danon-plans-novo-leaves-ascendis-lillys-latest-deal/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus news about Corbus, Syntis, Arrowhead, BioMarin, BioVie, Agomab, Antelope Therapeutics, Connect Biopharma and Genfit. Rocket Pharmaceuticals aligns with FDA on Danon: The commercial-stage biotech said it reached alignment with the ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}